Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus.

Master, Viraj A; Schmeusser, Benjamin N; Osunkoya, Adeboye O; Palacios, Arnold R; Midenberg, Eric; Yantorni, Lauren; Ogan, Kenneth; Bilen, Mehmet A.

Afiliação

Master VA; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Schmeusser BN; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Osunkoya AO; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Palacios AR; Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Midenberg E; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Yantorni L; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Ogan K; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.
Bilen MA; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.

J Immunother Precis Oncol ; 6(1): 50-55, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36751655